Next Article in Journal
The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors
Next Article in Special Issue
A Supramolecular Approach to Structure-Based Design with A Focus on Synthons Hierarchy in Ornithine-Derived Ligands: Review, Synthesis, Experimental and in Silico Studies
Previous Article in Journal
Lectin PLL3, a Novel Monomeric Member of the Seven-Bladed β-Propeller Lectin Family
Previous Article in Special Issue
A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles
Open AccessArticle

Covalent Inhibition of the Histamine H3 Receptor

Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands
Medicinal Chemistry Research Group, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok krt 2, H-1117 Budapest, Hungary
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2019, 24(24), 4541;
Received: 17 November 2019 / Revised: 6 December 2019 / Accepted: 8 December 2019 / Published: 11 December 2019
(This article belongs to the Special Issue Structure-Based Design of Biologically Active Compounds)
Covalent binding of G protein-coupled receptors by small molecules is a useful approach for better understanding of the structure and function of these proteins. We designed, synthesized and characterized a series of 6 potential covalent ligands for the histamine H3 receptor (H3R). Starting from a 2-amino-pyrimidine scaffold, optimization of anchor moiety and warhead followed by fine-tuning of the required reactivity via scaffold hopping resulted in the isothiocyanate H3R ligand 44. It shows high reactivity toward glutathione combined with appropriate stability in water and reacts selectively with the cysteine sidechain in a model nonapeptide equipped with nucleophilic residues. The covalent interaction of 44 with H3R was validated with washout experiments and leads to inverse agonism on H3R. Irreversible binder 44 (VUF15662) may serve as a useful tool compound to stabilize the inactive H3R conformation and to study the consequences of prolonged inhibition of the H3R. View Full-Text
Keywords: G protein-coupled receptor (GPCR); Histamine H3 receptor; covalent binder; isothiocyanate G protein-coupled receptor (GPCR); Histamine H3 receptor; covalent binder; isothiocyanate
Show Figures

Figure 1

MDPI and ACS Style

Wágner, G.; Mocking, T.A.M.; Kooistra, A.J.; Slynko, I.; Ábrányi-Balogh, P.; Keserű, G.M.; Wijtmans, M.; Vischer, H.F.; de Esch, I.J.P.; Leurs, R. Covalent Inhibition of the Histamine H3 Receptor. Molecules 2019, 24, 4541.

AMA Style

Wágner G, Mocking TAM, Kooistra AJ, Slynko I, Ábrányi-Balogh P, Keserű GM, Wijtmans M, Vischer HF, de Esch IJP, Leurs R. Covalent Inhibition of the Histamine H3 Receptor. Molecules. 2019; 24(24):4541.

Chicago/Turabian Style

Wágner, Gábor; Mocking, Tamara A.M.; Kooistra, Albert J.; Slynko, Inna; Ábrányi-Balogh, Péter; Keserű, György M.; Wijtmans, Maikel; Vischer, Henry F.; de Esch, Iwan J.P.; Leurs, Rob. 2019. "Covalent Inhibition of the Histamine H3 Receptor" Molecules 24, no. 24: 4541.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop